Skip to main content

Role of immune response in nonalcoholic fatty liver disease: Evidence in human and animal studies

Publication ,  Journal Article
Yang, L; Diehl, AM
December 1, 2007

Nonalcoholic fatty liver disease (NAFLD) is a spectrum of hepatic pathology ranging from nonalcoholic fatty liver (NAFL; steatosis) at the most clinically benign end of the spectrum to cirrhosis at the opposite extreme, where most liver-related morbidity and mortality occur. Nonalcoholic steatohepatitis (NASH) is a lesion of intermediate severity. NASH is characterized by overt hepatocyte injury and death. It is often accompanied by hepatic infiltration with inflammatory cells (1). Some individuals with NASH gradually accumulate hepatic fibrosis, and eventually develop cirrhosis (2). Over time, hepatocellular carcinomas emerge in a small proportion of individuals with NAFLD-related cirrhosis (3). The pathogenesis of NAFLD is the subject of much research because NAFLD is one of the most common causes of chronic liver disease, particularly in countries such as the United States that are in the midst of an obesity epidemic (4,(5)). © 2007 Humana Press Inc.

Duke Scholars

DOI

Publication Date

December 1, 2007

Start / End Page

337 / 345
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yang, L., & Diehl, A. M. (2007). Role of immune response in nonalcoholic fatty liver disease: Evidence in human and animal studies, 337–345. https://doi.org/10.1007/978-1-59745-518-3_27
Yang, L., and A. M. Diehl. “Role of immune response in nonalcoholic fatty liver disease: Evidence in human and animal studies,” December 1, 2007, 337–45. https://doi.org/10.1007/978-1-59745-518-3_27.
Yang, L., and A. M. Diehl. Role of immune response in nonalcoholic fatty liver disease: Evidence in human and animal studies. Dec. 2007, pp. 337–45. Scopus, doi:10.1007/978-1-59745-518-3_27.

DOI

Publication Date

December 1, 2007

Start / End Page

337 / 345